Skip to Content

← See all Senna Plus brands

Senna Plus by REMEDYREPACK INC.

Medically reviewed on February 28, 2018

Dosage form: tablet
Ingredients: SENNOSIDES 8.6mg, DOCUSATE SODIUM 50mg
Labeler: REMEDYREPACK INC.
NDC Code: 52125-675

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active ingredient (in each tablet)

Docusate Sodium 50 mg
Sennosides 8.6 mg

Purpose

Stool softener

Laxative

Uses
  • relieves occasional constipation (irregularity)
  • generally produces bowel movement in 6 to 12 hours

Warnings

Do not use for more than 1 week unless directed by a doctor

Ask a doctor before use if you -have abdominal  pain, nausea or vomiting -are taking mineral oil -have noticed a sudden change in bowel habits that  lasts over 2 weeks

Stop use and ask a doctor if -you have no bowel movement within 12 hours -you have rectal bleeding. these could signs of a serious condition.

if pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• do not exceed 8 tablets in 24 hours

Age
Starting Dose
Maximum Dose
adults and children 12 years of age and older
2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor
4 tablets in the morning and 4 tablets at bedtime
children under 12 years
ask a doctor

Other information

each tablet contains: calcium 7 mg

• store at room temperature

Inactive ingredients

cellulose, croscarmellose sodium, dicalcium phosphate, FD and C yellow no. 5 (tartrazine), FD and C yellow no. 6, hypromellose, magnesium silicate, magnesium stearate, mineral oil, PEG, sodium benzoate, sodium lauryl sulfate, starch, stearic acid, titanium dioxide, triacetin

DRUG: Senna Plus

GENERIC: Sennosides and Docusate Sodium

DOSAGE: TABLET

ADMINSTRATION: ORAL

NDC: 52125-675-02

COLOR: yellow

SHAPE: ROUND

SCORE: No score

SIZE: 10 mm

IMPRINT: CPC490

PACKAGING: 30 in 1 BLISTER PACK

ACTIVE INGREDIENT(S):

  • DOCUSATE SODIUM 50mg in 1
  • SENNOSIDES 8.6mg in 1

INACTIVE INGREDIENT(S):

  • CELLULOSE, MICROCRYSTALLINE
  • SODIUM BENZOATE
  • FD&C YELLOW NO. 6
  • SODIUM LAURYL SULFATE
  • FD&C YELLOW NO. 5
  • TITANIUM DIOXIDE
  • STARCH, CORN
  • STEARIC ACID
  • CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
  • CROSCARMELLOSE SODIUM
  • HYPROMELLOSES
  • MAGNESIUM SILICATE
  • MAGNESIUM STEARATE
  • POLYETHYLENE GLYCOLS
  • MINERAL OIL
  • TRIACETIN

SENNA PLUS 
sennosides and docusate sodium tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:52125-675(NDC:57896-455)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE 
CROSCARMELLOSE SODIUM 
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS 
MAGNESIUM SILICATE 
MAGNESIUM STEARATE 
MINERAL OIL 
POLYETHYLENE GLYCOLS 
HYPROMELLOSES 
FD&C YELLOW NO. 5 
FD&C YELLOW NO. 6 
SODIUM BENZOATE 
SODIUM LAURYL SULFATE 
STARCH, CORN 
STEARIC ACID 
TITANIUM DIOXIDE 
TRIACETIN 
Product Characteristics
ColoryellowScoreno score
ShapeROUNDSize10mm
FlavorImprint CodeCPC490
Contains    
Packaging
#Item CodePackage Description
1NDC:52125-675-0230 TABLET in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33407/19/2013
Labeler - REMEDYREPACK INC. (829572556)

 
REMEDYREPACK INC.

← See all Senna Plus brands

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide